FDA Moves Forward with Mail-back Envelopes for Opioid Analgesics Dispensed in Outpatient Settings
/PRNewswire/ -- Today, the U.S. Food and Drug Administration announced it is requiring manufacturers of opioid analgesics dispensed in outpatient settings to...
Source: prnewswire.com